Latest filing published 26 Nov 2025 for Kairos Pharma, LTD..
Insider track record
No signal scores available.
Hansoo Michael Keyoung: trading record in brief
Hansoo Michael Keyoung has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Kairos Pharma, Ltd. and CalciMedica, Inc. Over a trading history stretching from 29 September 2020 to 8 October 2025, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 26 November 2025, the filings show a share grant in Kairos Pharma, Ltd. The median gap between a trade and its publication by SEC (Form 4) is 49 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Hansoo Michael Keyoung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,084 shares0COMMON STOCKSEC:0001493152-25-025205:1
- 10,000 shares0COMMON STOCKSEC:0001493152-25-025205:0
- 1,133,596 sharesCommon StockSEC:0001209191-20-052340:0
3 of 3 declarations
